scispace - formally typeset
V

Vadim D. Vornik

Researcher at University of Texas Southwestern Medical Center

Publications -  6
Citations -  326

Vadim D. Vornik is an academic researcher from University of Texas Southwestern Medical Center. The author has contributed to research in topics: Surgical wound & Risk assessment. The author has an hindex of 5, co-authored 6 publications receiving 293 citations. Previous affiliations of Vadim D. Vornik include University of Texas Medical Branch.

Papers
More filters
Journal ArticleDOI

Evaluating an evidence-based bundle for preventing surgical site infection: a randomized trial.

TL;DR: An evidence-based intervention bundle did not reduce SSIs and the bundling of interventions, even when the constituent interventions have been individually tested, does not have a predictable effect on outcome.
Journal ArticleDOI

Prolonged recovery associated with dexmedetomidine when used as a sole sedative agent in office-based oral and maxillofacial surgery procedures.

TL;DR: In this paper, the authors performed a prospective pilot study in which patients undergoing office-based oral and maxillofacial surgical procedures received dexmedetomidine as a sole sedative agent.

Evaluating an Evidence-Based Bundle for Preventing Surgical Site Infection

TL;DR: In this paper, a combination of 5 evidenced-based practices (extended arm) or were treated according to the current practice (standard arm) were used to evaluate the SSI rate at 30 days assessed by blinded infection control coordinators.
Journal Article

Risk assessment in upper gastrointestinal haemorrhage: implications for resource utilisation.

TL;DR: It is suggested that this risk scoring system be adopted in hospitals for patients with acute upper GI bleeding to efficiently direct the use of 'intensive care' type facilities to those most at risk, and thereby optimise management.
Journal ArticleDOI

Lubeluzole inhibits accumulation of extracellular glutamate in the hippocampus during transient global cerebral ischemia.

TL;DR: It is suggested that lubeluzole is effective in inhibiting extracellular glutamate accumulation during global cerebral ischemia, and has the potential to produce potent neuroprotection when instituted prior to an ischemic event.